{"id":574418,"date":"2026-06-29T10:37:21","date_gmt":"2026-06-29T10:37:21","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/?p=574168"},"modified":"2026-06-30T08:25:01","modified_gmt":"2026-06-30T08:25:01","slug":"relacorilant-crl-fda-evidence-bar","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/blog\/relacorilant-crl-fda-evidence-bar\/","title":{"rendered":"Relacorilant\uff1a\u78ba\u7acb\u3055\u308c\u305f\u30a8\u30d3\u30c7\u30f3\u30b9\u57fa\u6e96\u3068\u65b0\u305f\u306a\u8a3c\u62e0\u306e\u30d0\u30e9\u30f3\u30b9"},"content":{"rendered":"<p><em>\u672c\u30d6\u30ed\u30b0\u8a18\u4e8b\u306f\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u304c2025\u5e7412\u670823\u65e5\u306bSanofi\u306e\u975e\u518d\u767a\u6027\u4e8c\u6b21\u9032\u884c\u578b\u591a\u767a\u6027\u786c\u5316\u75c7\uff08nrSP-MS\uff09\u6cbb\u7642\u85actolebrutinib\u306b\u5bfe\u3057\u3066\u3001\u307e\u305f2025\u5e7412\u670830\u65e5\u306bCorcept Therapeutics\u306e\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u6cbb\u7642\u85acrelacorilant\u306b\u5bfe\u3057\u3066\u767a\u884c\u3057\u305fComplete Response Letter\uff08CRL\uff09\u306b\u3064\u3044\u3066\u53d6\u308a\u4e0a\u3052\u308b\u30b7\u30ea\u30fc\u30ba\u306e\u7b2c3\u56de\u3067\u3059\u3002\u4e21\u85ac\u5264\u306f\u3044\u305a\u308c\u3082Clarivate\u300cDrugs to Watch 2026\u300d\u30ec\u30dd\u30fc\u30c8\u306b\u63b2\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u4eca\u56de\u306e\u5224\u65ad\u306f\u30ec\u30dd\u30fc\u30c8\u78ba\u5b9a\u5f8c\u306b\u4e0b\u3055\u308c\u307e\u3057\u305f\u3002 <\/em><\/p>\n<p><a href=\"https:\/\/corcept.gcs-web.com\/news-releases\/news-release-details\/corcept-receives-complete-response-letter-relacorilant-treatment\" target=\"_blank\" rel=\"noopener\">relacorilant<\/a>\u306b\u5bfe\u3059\u308bCRL\u306b\u304a\u3044\u3066\u3001FDA\u306f\u300cCorcept\u304c\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u8ffd\u52a0\u7684\u306a\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u63d0\u793a\u3057\u306a\u3044\u9650\u308a\u3001\u597d\u307e\u3057\u3044\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u306f\u5230\u9054\u3067\u304d\u306a\u3044\u300d\u3068\u7d50\u8ad6\u3065\u3051\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u85ac\u5264\u306e\u6709\u52b9\u6027\u3084\u5b89\u5168\u6027\u30c7\u30fc\u30bf\u305d\u306e\u3082\u306e\u3078\u306e\u61f8\u5ff5\u3092\u793a\u3057\u305f\u3082\u306e\u3067\u306f\u306a\u304f\u3001\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u304c\u30ea\u30b9\u30af\u3092\u4e0a\u56de\u308b\u3053\u3068\u3092\u6700\u7d42\u7684\u306b\u7acb\u8a3c\u3059\u308b\u306b\u306f\u3001\u3055\u3089\u306b\u591a\u304f\u306e\u8a3c\u62e0\u304c\u5fc5\u8981\u3060\u3068\u793a\u5506\u3057\u305f\u3082\u306e\u3067\u3059\u3002<\/p>\n<h3><strong>\u81e8\u5e8a\u7684\u80cc\u666f<\/strong><\/h3>\n<p>Relacorilant\u306f\u3001\u9078\u629e\u7684\u30b0\u30eb\u30b3\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\uff08SGRA\uff09\u3067\u3042\u308a\u3001\u30d7\u30ed\u30b2\u30b9\u30c6\u30ed\u30f3\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3059\u308b\u3053\u3068\u306a\u304f\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u30b7\u30b0\u30ca\u30eb\u3092\u906e\u65ad\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u65e2\u5b58\u6cbb\u7642\u3068\u306e\u5dee\u5225\u5316\u8981\u56e0\u306e1\u3064\u3067\u3059\u3002\u7570\u8cea\u6027\u306e\u9ad8\u3044\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u60a3\u8005\u96c6\u56e3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2c3\u76f8GRACE\u8a66\u9a13\u3067\u306f\u3001\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u3001\u9ad8\u8840\u5727\u3092\u6709\u3059\u308b\u60a3\u8005\u306b\u304a\u3044\u306622\u9031\u6642\u70b9\u3067\u53ce\u7e2e\u671f\u8840\u5727\u304a\u3088\u3073\u62e1\u5f35\u671f\u8840\u5727\u304c\u305d\u308c\u305e\u308c\u5e73\u5747-7.9 mmHg\u3001-5.1 mmHg\u6539\u5584\u3059\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\uff08\u3044\u305a\u308c\u3082P&lt;.0001\uff09\u3002<\/p>\n<p>\u4e00\u65b9\u3001\u3088\u308a\u9650\u5b9a\u3055\u308c\u305f\u60a3\u8005\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u3067\u3042\u308b\u3001\u526f\u814e\u817a\u816b\u307e\u305f\u306f\u904e\u5f62\u6210\u306b\u8d77\u56e0\u3059\u308b\u9ad8\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u75c7\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u5b9f\u65bd\u3055\u308c\u305fGRADIENT\u8a66\u9a13\u3067\u3082\u3001\u540c\u69d8\u306e\u8840\u5727\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u4e0a\u306e\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u304c\u793a\u3055\u308c\u307e\u3057\u305f\uff0822\u9031\u6642\u70b9\u306b\u304a\u3051\u308b\u6cbb\u7642\u5dee\uff1arelacorilant -6.6 mmHg\u3001\u30d7\u30e9\u30bb\u30dc -2.1 mmHg\uff09\u3002\u305f\u3060\u3057\u3001relacorilant\u7fa4\u3067\u306e\u4f4e\u4e0b\u81ea\u4f53\u306f\u7d71\u8a08\u5b66\u7684\u306b\u3082\u81e8\u5e8a\u7684\u306b\u3082\u6709\u610f\u3067\u3042\u3063\u305f\u3082\u306e\u306e\u3001relacorilant\u7fa4\u3068\u30d7\u30e9\u30bb\u30dc\u7fa4\u306e\u5dee\u306f\u6709\u610f\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>\u5e02\u5834\u3078\u306e\u5f71\u97ff<\/strong><\/h3>\n<p>\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u6bd4\u8f03\u7684\u5c0f\u898f\u6a21\u3067\u306f\u3042\u308b\u3082\u306e\u306e\u3001\u5927\u304d\u306a\u6a5f\u4f1a\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u30022025\u5e74\u6642\u70b9\u30673\u51048,300\u4e07\u301c3\u51048,600\u4e07\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u3066\u304a\u308a\u30012030\u5e74\u307e\u3067\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff095.64%\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002Corcept\u306f\u3001relacorilant\u304c\u627f\u8a8d\u5f8c3\u301c5\u5e74\u4ee5\u5185\u306b\u5404\u9069\u5fdc\u75c7\u3092\u901a\u3058\u3066\u5e74\u959330\u5104\u301c50\u5104\u30c9\u30eb\u3092\u7372\u5f97\u3057\u5f97\u308b\u3068\u898b\u8fbc\u3093\u3067\u304a\u308a\u3001\u3053\u308c\u306f\u9ad8\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u75c7\u5e02\u5834\u306750\u301c85%\u306e\u30b7\u30a7\u30a2\u306b\u76f8\u5f53\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>relacorilant\u306e\u7af6\u4e89\u4e0a\u306e\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u306f\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306b\u3042\u308a\u307e\u3059\u3002mifepristone\uff08Korlym\u00ae\u3001\u540c\u3058\u304fCorcept\u306e\u88fd\u54c1\uff09\u3068\u306f\u7570\u306a\u308a\u3001relacorilant\u306f\u30d7\u30ed\u30b2\u30b9\u30c6\u30ed\u30f3\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u306a\u3044\u305f\u3081\u3001\u5a66\u4eba\u79d1\u7cfb\u6709\u5bb3\u4e8b\u8c61\u3092\u6700\u592770%\u4f4e\u6e1b\u3067\u304d\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u4ed6\u306e\u6cbb\u7642\u3067\u898b\u3089\u308c\u308b\u526f\u814e\u4e0d\u5168\u3084\u4f4e\u30ab\u30ea\u30a6\u30e0\u8840\u75c7\u3082\u5f15\u304d\u8d77\u3053\u3057\u307e\u305b\u3093\u3002<\/p>\n<p>CRL\u306e\u767a\u8868\u5f8c\u3001Corcept\u306e\u682a\u4fa1\u306f50.4%\u4e0b\u843d\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u306f\u6295\u8cc7\u5bb6\u306e\u53cd\u5fdc\u3068\u958b\u767a\u30ea\u30b9\u30af\u8a55\u4fa1\u306e\u898b\u76f4\u3057\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<h3>\u660e\u308b\u3044\u6750\u6599\uff1a\u5375\u5de3\u304c\u3093\u9069\u5fdc\u3078\u306e\u9053\u7b4b<\/h3>\n<p>relacorilant\u306e\u627f\u8a8d\u306b\u5411\u3051\u305f\u9053\u306e\u308a\u306f\u3001\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u306b\u3068\u3069\u307e\u308a\u307e\u305b\u3093\u3002\u30d7\u30e9\u30c1\u30ca\u62b5\u6297\u6027\u5375\u5de3\u304c\u3093\u306b\u95a2\u3059\u308bNDA\u306ePDUFA\u5224\u65ad\u4e88\u5b9a\u65e5\u306f2026\u5e747\u670811\u65e5\u3067\u3059\u3002\u7b2c3\u76f8ROSELLA\u8a66\u9a13\u306e\u826f\u597d\u306a\u7d50\u679c\u304c\u7533\u8acb\u3092\u88cf\u4ed8\u3051\u3066\u304a\u308a\u3001relacorilant\u3068nab-paclitaxel\u306e\u4f75\u7528\u306f\u3001nab-paclitaxel\u5358\u72ec\u3068\u6bd4\u3079\u3066\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\uff086.5\u304b\u6708 vs 5.5\u304b\u6708\uff09\u304a\u3088\u3073\u5168\u751f\u5b58\u671f\u9593\uff0816.0\u304b\u6708 vs 11.5\u304b\u6708\uff09\u3067\u512a\u308c\u305f\u6210\u7e3e\u3092\u793a\u3057\u3001\u6bd2\u6027\u306e\u5897\u52a0\u3082\u8a8d\u3081\u3089\u308c\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u3053\u306eCRL\u306f\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u9069\u5fdc\u306b\u306e\u307f\u95a2\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u85ac\u5264\u5168\u4f53\u306e\u6709\u52b9\u6027\u30fb\u5b89\u5168\u6027\u306b\u5bfe\u3059\u308b\u5305\u62ec\u7684\u306a\u61f8\u5ff5\u3092\u610f\u5473\u3059\u308b\u3082\u306e\u3067\u306f\u306a\u304f\u3001\u5375\u5de3\u304c\u3093\u306e\u7533\u8acb\u3068\u306f\u72ec\u7acb\u3057\u305f\u6848\u4ef6\u3067\u3059\u3002<\/p>\n<p>\u73fe\u5728\u306e\u30d7\u30e9\u30c1\u30ca\u62b5\u6297\u6027\u5375\u5de3\u304c\u3093\u6cbb\u7642\u306b\u306f\u6301\u7d9a\u6027\u306e\u9650\u754c\u304c\u3042\u308a\u3001\u672a\u5145\u8db3\u30cb\u30fc\u30ba\u306f\u5927\u304d\u3044\u3068\u3044\u3048\u307e\u3059\u3002\u30d7\u30e9\u30c1\u30ca\u62b5\u6297\u6027\u5375\u5de3\u304c\u3093\u306e2\u6b21\u30fb3\u6b21\u6cbb\u7642\u85ac\u5e02\u5834\u306f2034\u5e74\u307e\u3067\u306b23\u5104\u30c9\u30eb\u898f\u6a21\u306b\u9054\u3057\u3001\u4e3b\u8981\u5e02\u5834\u58f2\u4e0a\u306e39%\u3092\u5360\u3081\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>Clarivate\u304c\u898f\u5236\u4e0a\u306e\u8ab2\u984c\u5bfe\u5fdc\u3092\u3069\u306e\u3088\u3046\u306b\u652f\u63f4\u3067\u304d\u308b\u304b<\/h3>\n<h4>Cortellis Regulatory Intelligence + AI\u642d\u8f09 Regulatory Assistant<\/h4>\n<p><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/research-development\/regulatory-compliance-intelligence\/regulatory-intelligence-solutions\/\">Cortellis Regulatory Intelligence<\/a> \u306f\u3001\u5e45\u5e83\u304f\u6df1\u3044\u77e5\u898b\u3068\u5c02\u9580\u6027\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u91cd\u8981\u306a\u898f\u5236\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u63d0\u4f9b\u3057\u3001<a href=\"https:\/\/clarivate.com\/ja\/news\/clarivate-presents-cortellis-regulatory-ai-assistant\/\">AI\u642d\u8f09\u6a5f\u80fd\u306b\u3088\u308a<\/a>Regulatory Assistant\u3092\u901a\u3058\u3066\u3055\u3089\u306b\u5f37\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002Corcept\u304c\u76f4\u9762\u3057\u3066\u3044\u308b\u306e\u306f\u5fae\u5999\u3067\u8907\u96d1\u306a\u898f\u5236\u4e0a\u306e\u8ab2\u984c\u3067\u3059\u3002FDA\u306f\u540c\u793e\u306e\u30c7\u30fc\u30bf\u81ea\u4f53\u306f\u8a8d\u3081\u3064\u3064\u3082\u3001\u3055\u3089\u306b\u591a\u304f\u306e\u8a3c\u62e0\u3092\u6c42\u3081\u3066\u3044\u307e\u3059\u3002Regulatory Assistant\u306f\u3001\u3053\u306e\u6587\u8108\u306b\u304a\u3044\u3066\u300c\u8ffd\u52a0\u7684\u306a\u30a8\u30d3\u30c7\u30f3\u30b9\u300d\u304c\u5177\u4f53\u7684\u306b\u4f55\u3092\u610f\u5473\u3059\u308b\u306e\u304b\u3092\u7406\u89e3\u3059\u308b\u52a9\u3051\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p><strong>FDA\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u57fa\u6e96\u3068\u6210\u529f\u4e8b\u4f8b\u3092\u7406\u89e3\u3059\u308b<\/strong><\/p>\n<ul>\n<li><strong>\u627f\u8a8d\u7d4c\u8def\u306b\u95a2\u3059\u308b\u5148\u4f8b\u306e\u7167\u4f1a\uff1a<\/strong>\u985e\u4f3c\u72b6\u6cc1\u3084\u6210\u529f\u3057\u305f\u89e3\u6c7a\u6226\u7565\u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306b\u3001Regulatory Assistant\u3078\u306e\u30af\u30a8\u30ea\u3068\u3057\u3066\u300c\u5e0c\u5c11\u5185\u5206\u6ccc\u75be\u60a3\u306b\u304a\u3044\u3066\u300eevidence\u4e0d\u8db3\u300f\u3092\u7406\u7531\u3068\u3059\u308bCRL\u5f8c\u306b\u627f\u8a8d\u518d\u7533\u8acb\u306b\u6210\u529f\u3057\u305f\u4e8b\u4f8b\u3092\u793a\u3057\u3066\u307b\u3057\u3044\u300d\u3084\u300c\u5c0f\u898f\u6a21\u60a3\u8005\u96c6\u56e3\u306b\u304a\u3051\u308b\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u95a2\u3059\u308bFDA\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u57fa\u6e96\u3092\u5206\u6790\u3057\u3066\u307b\u3057\u3044\u300d\u306a\u3069\u304c\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/li>\n<li><strong>\u30a8\u30d3\u30c7\u30f3\u30b9\u57fa\u6e96\u306e\u6bd4\u8f03: <\/strong>orcept\u306f\u3001\u9ad8\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u75c7\u306b\u95a2\u3059\u308bEMA\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u57fa\u6e96\u304cFDA\u3068\u7570\u306a\u308b\u304b\u3069\u3046\u304b\u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306b\u3001\u5404\u5730\u57df\u306e\u898f\u5236\u6226\u7565\u306e\u6bd4\u8f03\u8a55\u4fa1\u3092\u5206\u6790\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306fEU\u3067\u306e\u7533\u8acb\u6226\u7565\u3084\u3001FDA\u3078\u306e\u518d\u7533\u8acb\u306b\u5411\u3051\u305f\u8ad6\u62e0\u306e\u691c\u8a0e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002<\/li>\n<li><strong>\u8fc5\u901f\u5316\u7d4c\u8def\u306e\u5206\u6790\uff1a<\/strong>\u672c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u4fdd\u7559\u4e2d\u306e\u5375\u5de3\u304c\u3093\u9069\u5fdc\u3067\u306e\u627f\u8a8d\uff08PDUFA\u65e5\uff1a2026\u5e747\u670811\u65e5\uff09\u304b\u3089\u5f97\u3089\u308c\u308b\u8ffd\u52a0\u30c7\u30fc\u30bf\u304c\u3001\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u306e\u518d\u7533\u8acb\u3092\u652f\u3048\u5f97\u308b\u304b\u3069\u3046\u304b\u3092\u691c\u8a0e\u3059\u308b\u52a9\u3051\u306b\u306a\u308a\u307e\u3059\u3002\u8907\u6570\u9069\u5fdc\u75c7\u306e\u30c7\u30fc\u30bf\u304c\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u306e\u8b70\u8ad6\u3092\u5f37\u5316\u3057\u305f\u5148\u4f8b\u306e\u5206\u6790\u3082\u53ef\u80fd\u3067\u3059\u3002<\/li>\n<\/ul>\n<h4>DRG Fusion<\/h4>\n<p><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/real-world-data\/drg-fusion\/\">DRG Fusion<\/a> \u306f\u3001\u72ec\u81ea\u306b\u9023\u7d50\u3055\u308c\u305f\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30c7\u30fc\u30bf\u306b\u3088\u308a\u3001\u69d8\u3005\u306a\u89d2\u5ea6\u304b\u3089\u306e\u75be\u60a3\u5206\u6790\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002<\/p>\n<p><strong>\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30c7\u30fc\u30bf\u304b\u3089\u6709\u52b9\u6027\u30fb\u5b89\u5168\u6027\u3092\u88cf\u3065\u3051\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u5275\u51fa\u3059\u308b<\/strong><\/p>\n<ul>\n<li><strong>\u81ea\u7136\u6b74\u6bd4\u8f03\u5bfe\u7167\uff1a\u00a0<\/strong>RG Fusion\u306b\u7d71\u5408\u3055\u308c\u305f\u8acb\u6c42\u30c7\u30fc\u30bf\u3092\u7528\u3044\u308c\u3070\u3001\u672a\u6cbb\u7642\u307e\u305f\u306f\u6cbb\u7642\u4e0d\u5341\u5206\u306a\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u306e\u5b9f\u81e8\u5e8a\u3067\u306e\u9032\u884c\u3092\u7279\u5fb4\u3065\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u8a66\u9a13\u7d50\u679c\u3092\u6587\u8108\u3065\u3051\u3001\u81e8\u5e8a\u7684\u610f\u7fa9\u3092\u793a\u3059\u81ea\u7136\u6b74\u6bd4\u8f03\u304c\u53ef\u80fd\u3067\u3059\u3002<\/li>\n<li><strong>\u60a3\u8005\u30b8\u30e3\u30fc\u30cb\u30fc\u5206\u6790\uff1a<\/strong>\u672c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u60a3\u8005\u30b8\u30e3\u30fc\u30cb\u30fc\u5206\u6790\u30e2\u30b8\u30e5\u30fc\u30eb\u306b\u3088\u308a\u3001\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u60a3\u8005\u306e\u7d4c\u9a13\u3092\u53ef\u8996\u5316\u3057\u3001\u6cbb\u7642\u30ae\u30e3\u30c3\u30d7\u3001\u672a\u5145\u8db3\u30cb\u30fc\u30ba\u3001relacorilant\u304c\u610f\u5473\u306e\u3042\u308b\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u3092\u3082\u305f\u3089\u3059\u81e8\u5e8a\u6587\u8108\u3092\u793a\u3059\u3053\u3068\u3067\u3001\u81e8\u5e8a\u7684\u610f\u7fa9\u306b\u95a2\u3059\u308b\u4e3b\u5f35\u3092\u5f37\u5316\u3067\u304d\u307e\u3059\u3002<\/li>\n<li><strong>\u9577\u671f\u5b89\u5168\u6027\u306e\u691c\u8a3c\uff1a<\/strong>\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u306e\u5b89\u5168\u6027\u30c7\u30fc\u30bf\u306f\u8a66\u9a13\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u88dc\u5b8c\u3057\u3001\u9577\u671f\u7684\u306b\u8a31\u5bb9\u53ef\u80fd\u306a\u5fcd\u5bb9\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u793a\u3059\u3053\u3068\u3067\u3001\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306e\u5f37\u5316\u306b\u5bc4\u4e0e\u3057\u307e\u3059\u3002<\/li>\n<\/ul>\n<h4>Cortellis Clinical Trials Intelligence<\/h4>\n<p><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/research-development\/discovery-development\/cortellis-clinical-trials-intelligence\/\">Cortellis Clinical Trials Intelligence<\/a> \u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u9032\u6357\u3001\u7af6\u5408\u6226\u7565\u3001\u30d7\u30ed\u30c8\u30b3\u30eb\u8a2d\u8a08\u6700\u9069\u5316\u306b\u95a2\u3059\u308b\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u63d0\u4f9b\u3057\u3001\u8ffd\u52a0\u306e\u524d\u5411\u304d\u8a66\u9a13\u304c\u5fc5\u8981\u306a\u5834\u5408\u306b\u305d\u306e\u8a2d\u8a08\u6700\u9069\u5316\u3092\u652f\u63f4\u3067\u304d\u307e\u3059\u3002<br \/>\n<strong>\u6210\u529f\u78ba\u7387\u3092\u6700\u5927\u5316\u3059\u308b\u8ffd\u52a0\u8a66\u9a13\u3092\u8a2d\u8a08\u3059\u308b<\/strong><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>\u8a55\u4fa1\u9805\u76ee\u306e\u9078\u5b9a\uff1a<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\u9ad8\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u75c7\u306b\u95a2\u3057\u3066\u3001Corcept\u306f\u3001\u3069\u306e\u8a55\u4fa1\u9805\u76ee\uff08\u8840\u5727\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3001\u7cd6\u4ee3\u8b1d\u3001QOL\u3001\u4f53\u91cd\u6e1b\u5c11\uff09\u304c\u5e0c\u5c11\u5185\u5206\u6ccc\u75be\u60a3\u306b\u304a\u3044\u3066\u898f\u5236\u5f53\u5c40\u306b\u6700\u3082\u8aac\u5f97\u529b\u3092\u6301\u3063\u305f\u304b\u3092\u30d9\u30f3\u30c1\u30de\u30fc\u30af\u3067\u304d\u307e\u3059\u3002<\/p>\n<li><strong>\u65bd\u8a2d\u9078\u5b9a\u306e\u6700\u9069\u5316\uff1a2<\/strong>00\u304b\u56fd\u30fb27.7\u4e07\u8d85\u306e\u65bd\u8a2d\u30c7\u30fc\u30bf\u3092\u901a\u3058\u3066\u3001Corcept\u306f\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u306b\u95a2\u3059\u308b\u5c02\u9580\u6027\u3068\u60a3\u8005\u30a2\u30af\u30bb\u30b9\u5b9f\u7e3e\u3092\u5099\u3048\u305f\u5185\u5206\u6ccc\u30bb\u30f3\u30bf\u30fc\u3092\u7279\u5b9a\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306f\u5e0c\u5c11\u75be\u60a3\u3067\u306f\u91cd\u8981\u306a\u691c\u8a0e\u4e8b\u9805\u3067\u3059\u3002<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>\u30d7\u30ed\u30c8\u30b3\u30eb\u306e\u5b9f\u73fe\u53ef\u80fd\u6027\uff1a\u672c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u6210\u529f\u3057\u305f\u30d7\u30ed\u30c8\u30b3\u30eb\u3001\u65bd\u8a2d\u3001\u60a3\u8005\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u7406\u89e3\u3057\u3001\u75ab\u5b66\u30c7\u30fc\u30bf\u3001\u65bd\u8a2d\u306e\u7a3c\u50cd\u72b6\u6cc1\u3001\u30ea\u30af\u30eb\u30fc\u30c8\u30e1\u30f3\u30c8\u60c5\u5831\u3092\u7d71\u5408\u3057\u305f\u5e83\u7bc4\u306a\u65bd\u8a2d\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u8a55\u4fa1\u3059\u308b\u3053\u3068\u3067\u3001\u8a66\u9a13\u5b9f\u73fe\u53ef\u80fd\u6027\u3092\u5305\u62ec\u7684\u306b\u5206\u6790\u3067\u304d\u307e\u3059\u3002<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>\u5c64\u5225\u5316\u6226\u7565\uff1a\u5e0c\u5c11\u5185\u5206\u6ccc\u75be\u60a3\u8a66\u9a13\u306b\u304a\u3051\u308b\u6210\u529f\u3057\u305f\u60a3\u8005\u5c64\u5225\u5316\u30a2\u30d7\u30ed\u30fc\u30c1\u306e\u5206\u6790\u306b\u3088\u308a\u3001\u7570\u8cea\u6027\u306e\u3042\u308b\u60a3\u8005\u96c6\u56e3\u5168\u4f53\u3067\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u3092\u793a\u3059\u305f\u3081\u306e\u30d7\u30ed\u30c8\u30b3\u30eb\u8a2d\u8a08\u3092\u6700\u9069\u5316\u3067\u304d\u307e\u3059\u3002<\/li>\n<\/ul>\n<h4>Epidemiology Intelligence<\/h4>\n<p><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/portfolio-strategy\/market-assessment\/epidemiology-intelligence\/\">Epidemiology Intelligence<\/a> \u306f\u30011,000\u3092\u8d85\u3048\u308b\u75be\u60a3\u30fb\u51e6\u7f6e\u306b\u308f\u305f\u308b\u767a\u75c7\u7387\u30fb\u6709\u75c5\u7387\u306e\u6587\u732e\u30ec\u30d3\u30e5\u30fc\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u5e02\u5834\u898f\u6a21\u306e\u628a\u63e1\u3068\u60a3\u8005\u96c6\u56e3\u306e\u7406\u89e3\u3092\u652f\u63f4\u3057\u307e\u3059\u3002<\/p>\n<p><strong>\u6700\u3082\u660e\u78ba\u306a\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u304c\u793a\u3055\u308c\u308b\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u306e\u30b5\u30d6\u30dd\u30d4\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5b9a\u7fa9\u3059\u308b <\/strong><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u30b5\u30d6\u30dd\u30d4\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u7279\u5fb4\u3065\u3051\uff1a<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\u672c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3088\u308a\u3001\u75c5\u56e0\uff08\u4e0b\u5782\u4f53\u6027\u3001\u526f\u814e\u6027\u3001\u7570\u6240\u6027\uff09\u3001\u75be\u60a3\u91cd\u75c7\u5ea6\u3001\u4f75\u5b58\u75c7\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u5225\u306b\u5b9a\u7fa9\u3067\u304d\u307e\u3059\u3002<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>\u5bfe\u5fdc\u53ef\u80fd\u306a\u60a3\u8005\u96c6\u56e3\u306e\u5b9a\u91cf\u5316\uff1a\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u7d5e\u3063\u305f\u898f\u5236\u6226\u7565\u304a\u3088\u3073\u5546\u696d\u6226\u7565\u306e\u30b9\u30c8\u30ec\u30b9\u30c6\u30b9\u30c8\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>\u7cbe\u5bc6\u30bf\u30fc\u30b2\u30c6\u30a3\u30f3\u30b0\u306e\u8ad6\u62e0\u652f\u63f4\uff1a\u660e\u78ba\u306b\u5b9a\u7fa9\u3055\u308c\u305f\u30bb\u30b0\u30e1\u30f3\u30c8\u3067\u3001\u3069\u306e\u6226\u7565\u304c\u610f\u5473\u306e\u3042\u308b\u81e8\u5e8a\u7684\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u3092\u793a\u3059\u304b\u3092\u5224\u65ad\u3067\u304d\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>\u524d\u56de\u306e\u30d6\u30ed\u30b0\u8a18\u4e8b<a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/blog\/tolebrutinib-crl-safety-overrides-efficacy\">Tolebrutinib: when safety concerns override efficacy signals<\/a>, \u3067\u306f\u3001tolebrutinib\u306b\u5bfe\u3059\u308bCRL\u306e\u5f71\u97ff\u3068\u3001\u4fe1\u983c\u3067\u304d\u308b\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u304cFDA\u306e\u61f8\u5ff5\u3078\u306e\u5bfe\u5fdc\u306b\u3069\u306e\u3088\u3046\u306b\u5f79\u7acb\u3064\u304b\u3092\u8003\u5bdf\u3057\u307e\u3057\u305f\u3002\u672c\u30b7\u30ea\u30fc\u30ba\u306e <a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/what-comes-after-fda-complete-response-letter\">\u6b21\u56de\u304b\u3064\u6700\u7d42\u56de<\/a>\u3067\u306f\u3001 Sanofi\u3068Corcept\u306b\u3068\u3063\u3066\u306e\u793a\u5506\u3001\u304a\u3088\u3073\u4f01\u696d\u304cCRL\u5f8c\u306b\u3069\u306e\u3088\u3046\u306b\u524d\u9032\u306e\u9053\u7b4b\u3092\u63cf\u3051\u308b\u304b\u3092\u53d6\u308a\u4e0a\u3052\u307e\u3059\u3002<\/p>\n<p><em>Clarivate\u306e <a href=\"https:\/\/clarivate.com\/ja\/drugs-to-watch\/\">2026 Drugs to Watch \u5927\u304d\u306a\u671f\u5f85\u304c\u5bc4\u305b\u3089\u308c\u308b\u533b\u85ac\u54c111\u9078 <\/a>,\u8a73\u7d30\u3082\u305c\u3072\u3054\u89a7\u304f\u3060\u3055\u3044\u3002\u307e\u305f\u3001Clarivate\u304c<a href=\"https:\/\/clarivate.com\/ai\/\">AI<\/a>\u30c4\u30fc\u30eb\u3092\u3069\u306e\u3088\u3046\u306b\u6d3b\u7528\u3057\u3066\u3044\u308b\u304b\u306b\u3064\u3044\u3066\u3082\u3054\u89a7\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u304a\u5ba2\u69d8\u306f\u3088\u308a\u826f\u3044\u610f\u601d\u6c7a\u5b9a\u3092\u3088\u308a\u8fc5\u901f\u306b\u884c\u3048\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/em><\/p>\n<p>\u203b\u672c\u8a18\u4e8b\u306fClarivate.com\u306e\u82f1\u8a9e\u539f\u6587\u3092AI\u7ffb\u8a33\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u672c\u30d6\u30ed\u30b0\u8a18\u4e8b\u306f\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u304c2025\u5e7412\u670823\u65e5\u306bSanofi\u306e\u975e\u518d\u767a\u6027\u4e8c\u6b21\u9032\u884c\u578b\u591a\u767a\u6027\u786c\u5316\u75c7\uff08nrSP-MS\uff09\u6cbb\u7642\u85actolebrutinib\u306b\u5bfe\u3057\u3066\u3001\u307e\u305f2025\u5e7412\u670830\u65e5\u306bCorcept Therapeutics\u306e\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u6cbb\u7642\u85acrelacorilant\u306b\u5bfe\u3057\u3066\u767a\u884c\u3057\u305fComplete Response Letter\uff08CRL\uff09\u306b\u3064\u3044\u3066\u53d6\u308a\u4e0a\u3052\u308b\u30b7\u30ea\u30fc\u30ba\u306e\u7b2c3\u56de\u3067\u3059\u3002\u4e21\u85ac\u5264\u306f\u3044\u305a\u308c\u3082Clarivate\u300cDrugs to Watch 2026\u300d\u30ec\u30dd\u30fc\u30c8\u306b\u63b2\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u4eca\u56de\u306e\u5224\u65ad\u306f\u30ec\u30dd\u30fc\u30c8\u78ba\u5b9a\u5f8c\u306b\u4e0b\u3055\u308c\u307e\u3057\u305f\u3002 relacorilant\u306b\u5bfe\u3059\u308bCRL\u306b\u304a\u3044\u3066\u3001FDA\u306f\u300cCorcept\u304c\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u8ffd\u52a0\u7684\u306a\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u63d0\u793a\u3057\u306a\u3044\u9650\u308a\u3001\u597d\u307e\u3057\u3044\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u306f\u5230\u9054\u3067\u304d\u306a\u3044\u300d\u3068\u7d50\u8ad6\u3065\u3051\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u85ac\u5264\u306e\u6709\u52b9\u6027\u3084\u5b89\u5168\u6027\u30c7\u30fc\u30bf\u305d\u306e\u3082\u306e\u3078\u306e\u61f8\u5ff5\u3092\u793a\u3057\u305f\u3082\u306e\u3067\u306f\u306a\u304f\u3001\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u304c\u30ea\u30b9\u30af\u3092\u4e0a\u56de\u308b\u3053\u3068\u3092\u6700\u7d42\u7684\u306b\u7acb\u8a3c\u3059\u308b\u306b\u306f\u3001\u3055\u3089\u306b\u591a\u304f\u306e\u8a3c\u62e0\u304c\u5fc5\u8981\u3060\u3068\u793a\u5506\u3057\u305f\u3082\u306e\u3067\u3059\u3002 \u81e8\u5e8a\u7684\u80cc\u666f Relacorilant\u306f\u3001\u9078\u629e\u7684\u30b0\u30eb\u30b3\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\uff08SGRA\uff09\u3067\u3042\u308a\u3001\u30d7\u30ed\u30b2\u30b9\u30c6\u30ed\u30f3\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3059\u308b\u3053\u3068\u306a\u304f\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u30b7\u30b0\u30ca\u30eb\u3092\u906e\u65ad\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u65e2\u5b58\u6cbb\u7642\u3068\u306e\u5dee\u5225\u5316\u8981\u56e0\u306e1\u3064\u3067\u3059\u3002\u7570\u8cea\u6027\u306e\u9ad8\u3044\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u60a3\u8005\u96c6\u56e3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2c3\u76f8GRACE\u8a66\u9a13\u3067\u306f\u3001\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u3001\u9ad8\u8840\u5727\u3092\u6709\u3059\u308b\u60a3\u8005\u306b\u304a\u3044\u306622\u9031\u6642\u70b9\u3067\u53ce\u7e2e\u671f\u8840\u5727\u304a\u3088\u3073\u62e1\u5f35\u671f\u8840\u5727\u304c\u305d\u308c\u305e\u308c\u5e73\u5747-7.9 mmHg\u3001-5.1 mmHg\u6539\u5584\u3059\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\uff08\u3044\u305a\u308c\u3082P&lt;.0001\uff09\u3002 \u4e00\u65b9\u3001\u3088\u308a\u9650\u5b9a\u3055\u308c\u305f\u60a3\u8005\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u3067\u3042\u308b\u3001\u526f\u814e\u817a\u816b\u307e\u305f\u306f\u904e\u5f62\u6210\u306b\u8d77\u56e0\u3059\u308b\u9ad8\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u75c7\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u5b9f\u65bd\u3055\u308c\u305fGRADIENT\u8a66\u9a13\u3067\u3082\u3001\u540c\u69d8\u306e\u8840\u5727\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u4e0a\u306e\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u304c\u793a\u3055\u308c\u307e\u3057\u305f\uff0822\u9031\u6642\u70b9\u306b\u304a\u3051\u308b\u6cbb\u7642\u5dee\uff1arelacorilant -6.6 mmHg\u3001\u30d7\u30e9\u30bb\u30dc -2.1 mmHg\uff09\u3002\u305f\u3060\u3057\u3001relacorilant\u7fa4\u3067\u306e\u4f4e\u4e0b\u81ea\u4f53\u306f\u7d71\u8a08\u5b66\u7684\u306b\u3082\u81e8\u5e8a\u7684\u306b\u3082\u6709\u610f\u3067\u3042\u3063\u305f\u3082\u306e\u306e\u3001relacorilant\u7fa4\u3068\u30d7\u30e9\u30bb\u30dc\u7fa4\u306e\u5dee\u306f\u6709\u610f\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002 &nbsp; \u5e02\u5834\u3078\u306e\u5f71\u97ff \u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u6bd4\u8f03\u7684\u5c0f\u898f\u6a21\u3067\u306f\u3042\u308b\u3082\u306e\u306e\u3001\u5927\u304d\u306a\u6a5f\u4f1a\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u30022025\u5e74\u6642\u70b9\u30673\u51048,300\u4e07\u301c3\u51048,600\u4e07\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u3066\u304a\u308a\u30012030\u5e74\u307e\u3067\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff095.64%\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002Corcept\u306f\u3001relacorilant\u304c\u627f\u8a8d\u5f8c3\u301c5\u5e74\u4ee5\u5185\u306b\u5404\u9069\u5fdc\u75c7\u3092\u901a\u3058\u3066\u5e74\u959330\u5104\u301c50\u5104\u30c9\u30eb\u3092\u7372\u5f97\u3057\u5f97\u308b\u3068\u898b\u8fbc\u3093\u3067\u304a\u308a\u3001\u3053\u308c\u306f\u9ad8\u30b3\u30eb\u30c1\u30be\u30fc\u30eb\u75c7\u5e02\u5834\u306750\u301c85%\u306e\u30b7\u30a7\u30a2\u306b\u76f8\u5f53\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002 relacorilant\u306e\u7af6\u4e89\u4e0a\u306e\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u306f\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306b\u3042\u308a\u307e\u3059\u3002mifepristone\uff08Korlym\u00ae\u3001\u540c\u3058\u304fCorcept\u306e\u88fd\u54c1\uff09\u3068\u306f\u7570\u306a\u308a\u3001relacorilant\u306f\u30d7\u30ed\u30b2\u30b9\u30c6\u30ed\u30f3\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u306a\u3044\u305f\u3081\u3001\u5a66\u4eba\u79d1\u7cfb\u6709\u5bb3\u4e8b\u8c61\u3092\u6700\u592770%\u4f4e\u6e1b\u3067\u304d\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u4ed6\u306e\u6cbb\u7642\u3067\u898b\u3089\u308c\u308b\u526f\u814e\u4e0d\u5168\u3084\u4f4e\u30ab\u30ea\u30a6\u30e0\u8840\u75c7\u3082\u5f15\u304d\u8d77\u3053\u3057\u307e\u305b\u3093\u3002 CRL\u306e\u767a\u8868\u5f8c\u3001Corcept\u306e\u682a\u4fa1\u306f50.4%\u4e0b\u843d\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u306f\u6295\u8cc7\u5bb6\u306e\u53cd\u5fdc\u3068\u958b\u767a\u30ea\u30b9\u30af\u8a55\u4fa1\u306e\u898b\u76f4\u3057\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002 &nbsp; \u660e\u308b\u3044\u6750\u6599\uff1a\u5375\u5de3\u304c\u3093\u9069\u5fdc\u3078\u306e\u9053\u7b4b relacorilant\u306e\u627f\u8a8d\u306b\u5411\u3051\u305f\u9053\u306e\u308a\u306f\u3001\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u306b\u3068\u3069\u307e\u308a\u307e\u305b\u3093\u3002\u30d7\u30e9\u30c1\u30ca\u62b5\u6297\u6027\u5375\u5de3\u304c\u3093\u306b\u95a2\u3059\u308bNDA\u306ePDUFA\u5224\u65ad\u4e88\u5b9a\u65e5\u306f2026\u5e747\u670811\u65e5\u3067\u3059\u3002\u7b2c3\u76f8ROSELLA\u8a66\u9a13\u306e\u826f\u597d\u306a\u7d50\u679c\u304c\u7533\u8acb\u3092\u88cf\u4ed8\u3051\u3066\u304a\u308a\u3001relacorilant\u3068nab-paclitaxel\u306e\u4f75\u7528\u306f\u3001nab-paclitaxel\u5358\u72ec\u3068\u6bd4\u3079\u3066\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\uff086.5\u304b\u6708 vs 5.5\u304b\u6708\uff09\u304a\u3088\u3073\u5168\u751f\u5b58\u671f\u9593\uff0816.0\u304b\u6708 vs 11.5\u304b\u6708\uff09\u3067\u512a\u308c\u305f\u6210\u7e3e\u3092\u793a\u3057\u3001\u6bd2\u6027\u306e\u5897\u52a0\u3082\u8a8d\u3081\u3089\u308c\u307e\u305b\u3093\u3067\u3057\u305f\u3002 \u3055\u3089\u306b\u3001\u3053\u306eCRL\u306f\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u9069\u5fdc\u306b\u306e\u307f\u95a2\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u85ac\u5264\u5168\u4f53\u306e\u6709\u52b9\u6027\u30fb\u5b89\u5168\u6027\u306b\u5bfe\u3059\u308b\u5305\u62ec\u7684\u306a\u61f8\u5ff5\u3092\u610f\u5473\u3059\u308b\u3082\u306e\u3067\u306f\u306a\u304f\u3001\u5375\u5de3\u304c\u3093\u306e\u7533\u8acb\u3068\u306f\u72ec\u7acb\u3057\u305f\u6848\u4ef6\u3067\u3059\u3002&#8230;<\/p>\n","protected":false},"author":141,"featured_media":574164,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[1309],"tags":[1225,1120,2786,2734],"class_list":["post-574418","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharma","tag-fda","tag-regulatory-ja","tag-safety","tag-u-s","clarivate-industry-life-sciences-and-healthcare"],"acf":[],"lang":"ja","translations":{"ja":574418,"en":574168,"ko":579598},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/574418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/141"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=574418"}],"version-history":[{"count":7,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/574418\/revisions"}],"predecessor-version":[{"id":585340,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/574418\/revisions\/585340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/574164"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=574418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=574418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=574418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}